Correlation Between Atea Pharmaceuticals and Lyra Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Lyra Therapeutics, you can compare the effects of market volatilities on Atea Pharmaceuticals and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Lyra Therapeutics.

Diversification Opportunities for Atea Pharmaceuticals and Lyra Therapeutics

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Atea and Lyra is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Lyra Therapeutics go up and down completely randomly.

Pair Corralation between Atea Pharmaceuticals and Lyra Therapeutics

Given the investment horizon of 90 days Atea Pharmaceuticals is expected to generate 0.54 times more return on investment than Lyra Therapeutics. However, Atea Pharmaceuticals is 1.84 times less risky than Lyra Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  455.00  in Atea Pharmaceuticals on September 26, 2024 and sell it today you would lose (132.00) from holding Atea Pharmaceuticals or give up 29.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Atea Pharmaceuticals  vs.  Lyra Therapeutics

 Performance 
       Timeline  
Atea Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Atea Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Atea Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Lyra Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Atea Pharmaceuticals and Lyra Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atea Pharmaceuticals and Lyra Therapeutics

The main advantage of trading using opposite Atea Pharmaceuticals and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.
The idea behind Atea Pharmaceuticals and Lyra Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities